BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

940 related articles for article (PubMed ID: 28061688)

  • 1. Aptamers as Therapeutics.
    Nimjee SM; White RR; Becker RC; Sullenger BA
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():61-79. PubMed ID: 28061688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in SELEX and application of aptamers in the central nervous system.
    Yang Y; Yang D; Schluesener HJ; Zhang Z
    Biomol Eng; 2007 Dec; 24(6):583-92. PubMed ID: 17681489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
    Stoltenburg R; Reinemann C; Strehlitz B
    Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures.
    Rahimizadeh K; AlShamaileh H; Fratini M; Chakravarthy M; Stephen M; Shigdar S; Veedu RN
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29186905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of Specific Aptamers.
    Liu S; Suzuki Y; Inui M
    Methods Mol Biol; 2018; 1868():113-121. PubMed ID: 30244458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamers: selection, modification and application to nervous system diseases.
    Yang Y; Ren X; Schluesener HJ; Zhang Z
    Curr Med Chem; 2011; 18(27):4159-68. PubMed ID: 21838689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
    Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC
    J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three decades of nucleic acid aptamer technologies: Lessons learned, progress and opportunities on aptamer development.
    Wang T; Chen C; Larcher LM; Barrero RA; Veedu RN
    Biotechnol Adv; 2019; 37(1):28-50. PubMed ID: 30408510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamers selected by cell-SELEX for application in cancer studies.
    Zhang Y; Chen Y; Han D; Ocsoy I; Tan W
    Bioanalysis; 2010 May; 2(5):907-18. PubMed ID: 20657791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a fraction collection approach in capillary electrophoresis SELEX for aptamer selection.
    Luo Z; Zhou H; Jiang H; Ou H; Li X; Zhang L
    Analyst; 2015 Apr; 140(8):2664-70. PubMed ID: 25728760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in binder identification and characterisation: the case of oligonucleotide aptamers.
    Taouji S; Dausse E; Evadé L; Di Primo C; Toulmé JJ; Chevet E
    N Biotechnol; 2012 Jun; 29(5):550-4. PubMed ID: 22178698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current approaches in SELEX: An update to aptamer selection technology.
    Darmostuk M; Rimpelova S; Gbelcova H; Ruml T
    Biotechnol Adv; 2015 Nov; 33(6 Pt 2):1141-61. PubMed ID: 25708387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of whole-cell SELEX methods for the identification of Staphylococcus aureus-specific DNA aptamers.
    Moon J; Kim G; Park SB; Lim J; Mo C
    Sensors (Basel); 2015 Apr; 15(4):8884-97. PubMed ID: 25884791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleic Acid Aptamers as Emerging Tools for Diagnostics and Theranostics.
    Mutreja R; Baba SA; Navani NK
    Methods Mol Biol; 2019; 2054():201-221. PubMed ID: 31482458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamer Selection for Detecting Molecular Target Using Cell-SELEX (Systematic Evolution of Ligands by Exponential Enrichment) Technology.
    Stewart KD; Tan W; Park JY
    Methods Mol Biol; 2019; 2054():223-241. PubMed ID: 31482459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of DNA aptamers specific for small therapeutic peptides using a modified SELEX method.
    Lee J; Ryu M; Bae D; Kim HM; Eyun SI; Bae J; Lee K
    J Microbiol; 2022 Jul; 60(7):659-667. PubMed ID: 35731347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-SELEX optimization of aptamers.
    Gao S; Zheng X; Jiao B; Wang L
    Anal Bioanal Chem; 2016 Jul; 408(17):4567-73. PubMed ID: 27173394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamer Technology and Its Applications in Bone Diseases.
    Liu X; Hu J; Ning Y; Xu H; Cai H; Yang A; Shi Z; Li Z
    Cell Transplant; 2023; 32():9636897221144949. PubMed ID: 36591965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aptamers: characteristics and applications in pathogenic microorganism].
    Liang H; Yang S; Zhang T; Hu G; Xia X
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):698-703. PubMed ID: 21845835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generating aptamers by cell-SELEX for applications in molecular medicine.
    Ye M; Hu J; Peng M; Liu J; Liu J; Liu H; Zhao X; Tan W
    Int J Mol Sci; 2012; 13(3):3341-3353. PubMed ID: 22489154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.